HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Parlux Plays Mixed Doubles: Roddick Scent Will Follow Sharapova’s

This article was originally published in The Rose Sheet

Executive Summary

Parlux expects a men's fragrance inspired by tennis champion Andy Roddick will generate first-year sales of approximately $20 mil. at wholesale, Chairman & CEO Ilia Lekach said

You may also be interested in...



Parlux Serves Up Maria Sharapova Fragrance This Month

Maria Sharapova's premiere fragrance will roll out this month in seven Macy's East doors in the New York City area, according to Parlux

Parlux Serves Up Maria Sharapova Fragrance This Month

Maria Sharapova's premiere fragrance will roll out this month in seven Macy's East doors in the New York City area, according to Parlux

Parlux Looking To Ace Fragrance Category With Sharapova Deal

Parlux has signed an exclusive licensing agreement with Russian tennis star Maria Sharapova to develop a women's fragrance that will be targeted to younger consumers ages 15 to 25, according to the fragrance marketer

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012689

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel